Stack

KPV

Also known as Alpha-MSH fragment

What it is: Tripeptide fragment
What it does: Studied for anti-inflammatory signaling and gut-related effects
Status: Experimental
Evidence: Low. Mostly preclinical and mechanistic research.
Uses: Inflammation; gut health research

Caution. Human evidence is limited.

Summary

KPV is the Lys-Pro-Val C-terminal tripeptide of alpha-MSH that retains anti-inflammatory activity in cellular and animal models. It has been studied in gut inflammation, mucosal protection, and skin models, often in combination with other peptides. Human data are minimal, and dosing paradigms are not standardized, so it remains experimental.

Checked Jul 15, 2026.

Keep a record of KPV in Stack

Stack logs each dose you take, tracks what is left in the vial or bottle and shows how you kept to your plan. It records what you choose and does not recommend anything. Everything stays on your phone, with no account.

Get Stack on Google Play Peptide reconstitution calculator

More peptides

HGHApproved · high evidence TesamorelinApproved for one indication · moderate evidence SermorelinExperimental · low evidence CJC-1295 with DACExperimental · low evidence CJC-1295 without DACExperimental · low evidence

This entry summarises published information in plain language. It is not medical advice, a dosing recommendation or a substitute for a qualified healthcare professional. Many peptides are not approved for human use, and legal status varies by country. Check anything you rely on against primary sources.